Supermarkets and hypermarkets serve as significant distribution channels in the nicotine gum market, offering wide accessibility and convenience to consumers. These large retail outlets stock a variety of nicotine gum products, catering to different strengths and flavors, making it easier for customers to find suitable options for smoking cessation. Thus, the China market registered a volume of 991.80 thousand units in 2023.
The China market dominated the Asia Pacific Nicotine Gum Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $122.7 million by 2031. The Japan market is registering a CAGR of 5.4% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.8% during (2024 - 2031)
Many governments and healthcare authorities endorse nicotine gum as part of comprehensive smoking cessation programs. Healthcare providers often recommend nicotine gum through healthcare systems, pharmacies, and online platforms. Government subsidies, reimbursement programs, and inclusion in public health initiatives further support its adoption by making it more accessible and affordable for smokers.
Nicotine gum appeals to smokers who prefer self-directed methods for quitting smoking. Unlike prescription medications or nicotine patches that require healthcare provider involvement, nicotine gum is available over the counter in many countries. This accessibility allows smokers to initiate and manage their quitting process independently, which aligns with the trend toward consumer empowerment in healthcare decisions.
The focus on smoking control in China drives market growth for nicotine gum by creating a conducive environment for manufacturers to innovate and expand their product offerings. There is a push towards developing new formulations, improving taste profiles, and enhancing the effectiveness of nicotine gum, which appeals to a larger segment of the population seeking effective smoking cessation solutions. Therefore, increasing smoking control in the region is propelling the market's growth.
List of Key Companies Profiled
- Johnson & Johnson
- Novartis AG
- ITC Limited
- Cipla Limited
- Perrigo Company PLC
- Philip Morris International, Inc.
- ALCHEM INTERNATIONAL PVT. LTD.
- Alkalon A/S
Market Report Segmentation
By Type (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)- 2 mg
- 4 mg
- Pharmacies
- Supermarkets & Hypermarkets
- Online Stores
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Johnson & Johnson
- Novartis AG
- ITC Limited
- Cipla Limited
- Perrigo Company PLC
- Philip Morris International, Inc.
- ALCHEM INTERNATIONAL PVT. LTD.
- Alkalon A/S
Methodology
LOADING...